Discover 1,506 paid clinical trials in Loveland, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,506
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
Location: Denver CO, Nashville TN, Fairfax VA, Trumbull CT,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07519655
Phase 1, Recruiting
Gene Therapy for HER-Positive Cancer (SENTRY-HER2)
for
HER2 Expressing Solid Tumors
Location: Denver CO, Rochester MN, Los Angeles CA, Houston TX,
Sponsor: Vironexis Biotherapeutics Inc.
Sex: All
Age: 18+
Code: NCT07192432
Phase 1, Phase 2, Recruiting
An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers
for
Advanced Malignancies, Advanced Cancer
Location: Denver CO, Calgary, Nashville TN, Atlanta GA, Toronto,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07426757
Phase 1, Recruiting
Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation
Location: Denver CO, Dallas TX, Chicago IL, Houston TX, Eugene OR,
Sponsor: Institut de Recherches Internationales Servier
Sex: All
Age: 18+
Code: NCT06465953
Phase 3, Recruiting
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
for
MTAP-deleted Solid Tumors
Location: Denver CO, Irving TX, San Antonio TX, Milwaukee WI,
Sponsor: Bayer
Sex: All
Age: 18+
Code: NCT06914128
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
for
Infusion Reactions
Location: Denver CO, Aurora CO, Omaha NE, Oklahoma City OK,
Sponsor: New York Blood Center
Sex: All
Age: 0+
Code: NCT01656603
Phase 2, Recruiting
The NGAL Test™ As An Aid in the Risk Assessment for AKI Stage II and III in an Intensive Care Population
for
Kidney Injury
Location: Denver CO, Boston MA
Sponsor: BioPorto Diagnostics
Sex: All
Age: 18+
Code: NCT03057457
Recruiting
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
for
Chronic Lymphocytic Leukemia (CLL),
Location: Denver CO, Salt Lake City UT, Duarte CA, Chicago IL,
Sponsor: Nurix Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT04830137
Phase 1, Recruiting
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML